Jiaping Li

5.3k citations
163 papers · 4.1k · 4 hit papers · h-index 34

Impact in

  • Hepatology top 0.5%
    • Hepatocellular Carcinoma Treatment and Prognosis
  • Oncology top 5%
    • Cancer Immunotherapy and Biomarkers
    • Cancer Cells and Metastasis

Papers in

Jiaping Li

157 papers receiving 4k citations

Jiaping Li's Hit Papers

Immune checkpoint inhibitors and anti-vascular endothelial growth factor antibody/tyrosine kinase inhibitors with or without transarterial chemoembolization as first-line treatment for advanced hepatocellular carcinoma (CHANCE2201): a target trial emulation study 2024 · 106 citations
1060+1+2Years since publication100200300

Peers

Jiaping Li
Comparison fields: 5 of 106
  • Hepatology 2.1k
  • Oncology 475
  • Genetics 83
  • Pulmonary and Respiratory Medicine 271
  • Biomedical Engineering 298
Replace Hee Chul Park with:
Hee Chul Park South Korea
Yuta Abe Japan
Guihua Chen China
Boheng Zhang China
Henning Wege Germany
Osamu Itano Japan
Kenichi Taguchi Japan
Manabu Morimoto Japan
Minoru Kitago Japan
Jian‐Hong Zhong China
Jiaping Li relative to Hee Chul Park South Korea Hee Chul Park's profile →
Citations per field
00.5×2×3.4×
Hee Chul Park · 1×
Citations per year

Countries citing papers authored by Jiaping Li

Since Specialization
Citations

This map shows the geographic impact of Jiaping Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiaping Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiaping Li more than expected).

Fields of papers citing papers by Jiaping Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jiaping Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiaping Li. The network helps show where Jiaping Li may publish in the future.

Co-authors

The 25 scholars most cited alongside Jiaping Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Jiaping Li Line = papers co-authored together Jiaping Li links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 163 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Lenvatinib Combined With Transarterial Chemoembolization as First-Line Treatment for Advanced Hepatocellular Carcinoma: A Phase III, Randomized Clinical Trial (LAUNCH)
Hit paper breakdown →
2022333
2
Transarterial chemoembolization with PD-(L)1 inhibitors plus molecular targeted therapies for hepatocellular carcinoma (CHANCE001)
Hit paper breakdown →
2023212
3 2019206
4
TREM2+ macrophages suppress CD8+ T-cell infiltration after transarterial chemoembolisation in hepatocellular carcinoma
Hit paper breakdown →
2023177
5 2020159
6 2009140
7
Immune checkpoint inhibitors and anti-vascular endothelial growth factor antibody/tyrosine kinase inhibitors with or without transarterial chemoembolization as first-line treatment for advanced hepatocellular carcinoma (CHANCE2201): a target trial emulation study
Hit paper breakdown →
2024106
8 2020105
9 200983
10 201283
11 201581
12 202179
13 201675
14 202374
15 201169
16 201565
17 201864
18 201055
19 201953
20 201950

About Jiaping Li

Jiaping Li is a scholar working on Hepatology, Pulmonary and Respiratory Medicine, Oncology, Radiology, Nuclear Medicine and Imaging and Surgery, having authored 163 papers that have together received 4.1k indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (91 papers), Sarcoma Diagnosis and Treatment (8 papers), Cancer Immunotherapy and Biomarkers (6 papers), Radiomics and Machine Learning in Medical Imaging (6 papers), Nanoplatforms for cancer theranostics (4 papers), Gallbladder and Bile Duct Disorders (4 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (3 papers) and Liver Disease and Transplantation (3 papers). The work is most often cited by research in Hepatology (2.1k citations), Oncology (475 citations), Genetics (83 citations), Pulmonary and Respiratory Medicine (271 citations) and Biomedical Engineering (298 citations). Jiaping Li has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Wenzhe Fan, Jizhou Tan, Baogang Peng, Yingqiang Zhang, Jianyong Yang, Ting Liu, Bowen Zhu, Yu Wang, Zhenwei Peng and Yonghui Huang. Their work appears in journals such as Frontiers in Oncology, European Radiology, Journal of Vascular and Interventional Radiology, Oncotarget and International Journal of Hyperthermia.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact